CLINICAL_TRIALS
withdrawal
· 2017-09-26
Clinical Trial Update: Epidural Morphine for Analgesia After Traumatic Vaginal Delivery [Phase 4]
Summary
A Phase 4 trial evaluating epidural morphine for analgesia after traumatic vaginal delivery was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Traumatic Vaginal Delivery | Phase 4 | Status: WITHDRAWN